Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Clinical Cancer Research
Personen und Körperschaften: Bernhardt, Mathias, Orouji, Elias, Larribere, Lionel, Gebhardt, Christoffer, Utikal, Jochen
In: Clinical Cancer Research, 20, 2014, 9, S. 2498-2499
Format: E-Article
Sprache: Englisch
veröffentlicht:
American Association for Cancer Research (AACR)
Schlagwörter:
Cancer Research
Oncology
author_facet Bernhardt, Mathias
Orouji, Elias
Larribere, Lionel
Gebhardt, Christoffer
Utikal, Jochen
Bernhardt, Mathias
Orouji, Elias
Larribere, Lionel
Gebhardt, Christoffer
Utikal, Jochen
author Bernhardt, Mathias
Orouji, Elias
Larribere, Lionel
Gebhardt, Christoffer
Utikal, Jochen
spellingShingle Bernhardt, Mathias
Orouji, Elias
Larribere, Lionel
Gebhardt, Christoffer
Utikal, Jochen
Clinical Cancer Research
Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
Cancer Research
Oncology
author_sort bernhardt, mathias
spelling Bernhardt, Mathias Orouji, Elias Larribere, Lionel Gebhardt, Christoffer Utikal, Jochen 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-13-2349 Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter Clinical Cancer Research
doi_str_mv 10.1158/1078-0432.ccr-13-2349
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTEzLTIzNDk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTEzLTIzNDk
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Association for Cancer Research (AACR), 2014
imprint_str_mv American Association for Cancer Research (AACR), 2014
issn 1078-0432
1557-3265
issn_str_mv 1078-0432
1557-3265
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str bernhardt2014efficacyofvemurafenibinatrametinibresistantstageivmelanomapatientletter
publishDateSort 2014
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Clinical Cancer Research
source_id 49
title Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_unstemmed Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_full Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_fullStr Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_full_unstemmed Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_short Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_sort efficacy of vemurafenib in a trametinib-resistant stage iv melanoma patient—letter
topic Cancer Research
Oncology
url http://dx.doi.org/10.1158/1078-0432.ccr-13-2349
publishDate 2014
physical 2498-2499
description
container_issue 9
container_start_page 2498
container_title Clinical Cancer Research
container_volume 20
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792328300666814466
geogr_code not assigned
last_indexed 2024-03-01T12:51:05.94Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Efficacy+of+Vemurafenib+in+a+Trametinib-Resistant+Stage+IV+Melanoma+Patient%E2%80%94Letter&rft.date=2014-05-01&genre=article&issn=1557-3265&volume=20&issue=9&spage=2498&epage=2499&pages=2498-2499&jtitle=Clinical+Cancer+Research&atitle=Efficacy+of+Vemurafenib+in+a+Trametinib-Resistant+Stage+IV+Melanoma+Patient%E2%80%94Letter&aulast=Utikal&aufirst=Jochen&rft_id=info%3Adoi%2F10.1158%2F1078-0432.ccr-13-2349&rft.language%5B0%5D=eng
SOLR
_version_ 1792328300666814466
author Bernhardt, Mathias, Orouji, Elias, Larribere, Lionel, Gebhardt, Christoffer, Utikal, Jochen
author_facet Bernhardt, Mathias, Orouji, Elias, Larribere, Lionel, Gebhardt, Christoffer, Utikal, Jochen, Bernhardt, Mathias, Orouji, Elias, Larribere, Lionel, Gebhardt, Christoffer, Utikal, Jochen
author_sort bernhardt, mathias
container_issue 9
container_start_page 2498
container_title Clinical Cancer Research
container_volume 20
description
doi_str_mv 10.1158/1078-0432.ccr-13-2349
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTEzLTIzNDk
imprint American Association for Cancer Research (AACR), 2014
imprint_str_mv American Association for Cancer Research (AACR), 2014
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1078-0432, 1557-3265
issn_str_mv 1078-0432, 1557-3265
language English
last_indexed 2024-03-01T12:51:05.94Z
match_str bernhardt2014efficacyofvemurafenibinatrametinibresistantstageivmelanomapatientletter
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 2498-2499
publishDate 2014
publishDateSort 2014
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Clinical Cancer Research
source_id 49
spelling Bernhardt, Mathias Orouji, Elias Larribere, Lionel Gebhardt, Christoffer Utikal, Jochen 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-13-2349 Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter Clinical Cancer Research
spellingShingle Bernhardt, Mathias, Orouji, Elias, Larribere, Lionel, Gebhardt, Christoffer, Utikal, Jochen, Clinical Cancer Research, Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter, Cancer Research, Oncology
title Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_full Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_fullStr Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_full_unstemmed Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_short Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
title_sort efficacy of vemurafenib in a trametinib-resistant stage iv melanoma patient—letter
title_unstemmed Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
topic Cancer Research, Oncology
url http://dx.doi.org/10.1158/1078-0432.ccr-13-2349